N
8.97
0.32 (3.70%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | NeOnc Technologies Holdings, In | - | - |
AIStockmoo 评分
-0.1
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.13 |
|
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA). |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 53.00% |
| 机构持股比例 | 0.31% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Westmount Partners, Llc | 31 Dec 2025 | 43,320 |
| Hcr Wealth Advisors | 31 Dec 2025 | 15,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合